PFCs were defined as PPs and WOPNs according to the revised Atlanta classification,1 and subsequently as sterile or infected based on the presence of signs of infection (fever, increased WBC or CRP, and/or evidence of gas bubbles at imaging examinations). PFCs were evaluated through computed tomography (CT) and EUS. The indications for PFC drainage were: refractory abdominal pain, impaired gastric outlet, anorexia and infected PFCs, according to current guidelines.5,6 Presence of regional varices, suspected cystic neoplasms, coagulopathy (International Normalized Ratio. INR > 1.5), thrombocytopenia (platelets < 50.000/mm3) or absence of close proximity of PFC walls to EUS probe (>1 cm) were exclusion criteria. Technical success was defined as the ability to position and deploy the stent. Clinical success was defined as at least a 50% decrease in the PFC size based on radiological evaluation (either CT scan and/or magnetic resonance imaging) analysis at 30 days, associated with clinical resolution of the symptoms considered the primary indication to the procedure.
Adverse events were defined as: immediate peri-procedural (<24 hours), post-procedural early (<7 days) and delayed (>7 days).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.